Minglei Han

机构：Nanchang University, Shanghai Jiao Tong University, Shanghai Eye Disease Prevention & Treatment Center, Shanghai Ninth People's Hospital, Shanghai Institute of Hematology, Henan Agricultural University · ORCID：0000-0002-0020-0825

发表论文 28 篇 · 总被引 283 次 · h-index 10

代表论文

• Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial (2023 · The Lancet Child & Adolescent Health · 被引 41)
• Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting (2021 · Small Methods · 被引 40)
• Eye-Preserving Therapies for Advanced Retinoblastoma (2021 · Ophthalmology · 被引 31)
• Contemporary Update of Retinoblastoma in China: Three-Decade Changes in Epidemiology, Clinical Features, Treatments, and Outcomes (2021 · American Journal of Ophthalmology · 被引 25)
• Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients (2021 · Experimental Eye Research · 被引 22)
• Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy (2021 · British Journal of Ophthalmology · 被引 17)